Lubiprostone produces spontaneous bowel movements within 24 and 48 hours in patients with chronic constipation

被引：0
|
作者：
Ueno, Ryuji [1 ]
Wahle, Aimee [1 ]
机构：
[1] Sucampo Pharmaceut Inc, Med & Sci Affairs, Bethesda, MD USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-01268
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1268
引用
收藏
页码：S490 / S491
页数：2
相关论文
共 50 条
  • [21] Comparison of patients with acute Small Bowel Obstruction operated within 24 hours of admission and those operated beyond 24 hours of admission
    Bukhari, Hina
    Butt, Hafiza Kiran Saleem
    Sirichand
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (03): : 497 - 499
  • [22] The effect of lubiprostone on small intestinal bacterial overgrowth in patients with chronic idiopathic constipation
    Sarosiek, I.
    Sarosiek, J.
    Gomez, Y.
    Mccallum, R.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 : 22 - 22
  • [23] Impact of Enteral Nutrition Within 24 Hours Versus Between 24 and 48 Hours in Patients With Severe Acute Pancreatitis: A Multicenter Retrospective Study
    Nakashima, Ikue
    Horibe, Masayasu
    Sanui, Masamitsu
    Sasaki, Mitsuhito
    Sawano, Hirotaka
    Goto, Takashi
    Ikeura, Tsukasa
    Takeda, Tsuyoshi
    Oda, Takuya
    Yasuda, Hideto
    Ogura, Yuki
    Miyazaki, Dai
    Kitamura, Katsuya
    Chiba, Nobutaka
    Ozaki, Tetsu
    Yamashita, Takahiro
    Koinuma, Toshitaka
    Oshima, Taku
    Yamamoto, Tomonori
    Hirota, Morihisa
    Moriya, Takashi
    Shirai, Kunihiro
    Izai, Junko
    Takeda, Kazunori
    Sekino, Motohiro
    Iwasaki, Eisuke
    Kanai, Takanori
    Mayumi, Toshihiko
    PANCREAS, 2021, 50 (03) : 371 - 377
  • [24] Effects of Lubiprostone on Gastric Motor and Sensory Function in Patients With Chronic Idiopathic Constipation
    Lacy, Brian E.
    Loew, Burr J.
    Crowell, Michael D.
    GASTROENTEROLOGY, 2011, 140 (05) : S530 - S530
  • [25] The Efficacy of Lubiprostone Is Not Affected by Body Mass Index in Patients With Chronic Idiopathic Constipation
    Rao, Satish
    Johanson, John
    Wang, Martin
    Mareya, Shadreck
    Lichtlen, Peter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S759 - S759
  • [26] PATTERNS OF PHARMACOTHERAPY IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION INITIATING TREATMENT WITH LINACLOTIDE OR LUBIPROSTONE
    Bornheimer, Rebecca K.
    Gerbasi, Margaret
    Nag, Arpita
    Oster, Gerry
    GASTROENTEROLOGY, 2018, 154 (06) : S757 - S757
  • [27] Risk Factors for Adverse Events in Patients with Chronic Constipation Following Lubiprostone Administration
    Eguchi, Takaaki
    Yoshizaki, Tetsuya
    Takagi, Megumi
    Ikeoka, Seitaro
    Hashimura, Hiroki
    Okamoto, Norihiro
    Matsumoto, Masanori
    Matsuda, Tatsuya
    Miura, Takahiro
    Momose, Kenji
    Otsuka, Takashi
    Morisawa, Toshiyuki
    Okada, Akihiko
    DIGESTIVE DISEASES, 2021, 39 (01) : 10 - 15
  • [28] Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study
    Ooba, Nobuhiro
    Takahashi, Yoshinori
    Nagamura, Marina
    Takahashi, Masao
    Ushida, Makoto
    Kawakami, Eiji
    Kimura, Masaomi
    Sato, Tsugumichi
    Tokuyoshi, Junichi
    Miyazaki, Choichiro
    Shimada, Mitsuaki
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (12) : 1553 - 1558
  • [29] Durability and Predictability of Treatment Response to Lubiprostone in Patients With Constipation-Predominant Irritable Bowel Syndrome
    Fass, Ronnie
    Chey, William D.
    Wang, Martin
    Mareya, Shadreck
    Losch-Beridon, Taryn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S761 - S761
  • [30] Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
    Chey, W. D.
    Drossman, D. A.
    Johanson, J. F.
    Scott, C.
    Panas, R. M.
    Ueno, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (05) : 587 - 599
12345